84-4352-59 Fra-2 100ul 316407
特徴
- Controls osteoclast survival and size By similarity.
- As a dimer with JUN, activates LIF transcription By similarity.
- Activates CEBPB transcription in PGE2-activated osteoblasts By similarity.Masao Murakami, Cell Growth Differ., May 1999; 10: 333.
- Martin Smith, Mol.
- Cell.
- Biol., Jun 2001; 21: 3704 - 3713.
- L.
- K.
- Mccauley, Endocrinology, May 2001; 142: 1975.
- Tetsuo Yoshida, Nucleic Acids Res., Jun 1993; 21: 2715 - 2721.
- Applications:Suitable for use in Western Blot and Immunohistochemistry.
- Other applications not tested.
- Recommended Dilution:Western Blot: 1:500-1:3000Immunohistochemistry: 1:50-1:100Optimal dilutions to be determined by the researcher.
- Storage and Stability:May be stored at 4°C for short-term only.
- Aliquot to avoid repeated freezing and thawing.
- Store at -20°C.
- Aliquots are stable for 12 months after receipt.
- For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
仕様
- Size：100ul
- Host：rabbit
- Source Antibody：human
- Grade：Affinity Purified
- Purity：Purified by immunoaffinity chromatography.
- Form：Supplied as a liquid in PBS, pH 7.4, 150mM sodium chloride, 0.02% sodium azide, 50% glycerol.
- Specificity：Species Crossreactivity: mouse and rat
- Isotype：IgG
- Calc Applications Abbrev：IHC WB
- Calc Crossreactivity：Hu Mo Rt
- Immunogen：Synthetic peptide corresponding to human Fra-2.
- Shelf Life：1year
- Swiss Prot Number：P15408
- EU Commodity Code：30021010
- この商品は法規制を確認しておりません。（法規制によって販売できない場合もございます）
- 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
- 【試薬に関するお問合せ】
- アズワン株式会社 試薬・プロセス材料グループ
- TEL：06-6447-8641
- FAX：06-6447-8642
- E-mail：[email protected]
